Ketokonazol Pinewood Laboratories (Ketoconazole)

Ketoconazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for synthesising ergosterol, a key component of the fungal cell membrane. Inhibiting ergosterol production compromises membrane integrity, leading to increased permeability, disrupted cellular processes, and ultimately fungal cell death.

The specific dosage and frequency of Ketokonazol are determined by the prescribing healthcare professional based on the infection type, severity, patient age, and treatment guidelines. Patients should follow the prescriber’s instructions and the product label for proper application.

Safety data for topical ketoconazole in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing to pregnant or nursing individuals. Women should discuss their situation with a qualified clinician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Ketokonazol is an imidazole antifungal, offering broad‑spectrum activity against dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, ketoconazole has a slightly different mechanism and may be preferred for certain yeast‑driven conditions like seborrheic dermatitis. Choice of therapy depends on infection type, patient factors, and clinician preference.

Ketokonazol should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and ensure it is out of reach of children.

Ketokonazol is applied topically to clean, dry skin. A thin layer is spread over the affected area, usually once or twice daily as directed by the prescriber. Hands should be washed after application, and the treated skin should not be covered with occlusive dressings unless advised.

Serious risks, though rare, include severe allergic reactions such as angioedema, anaphylaxis, extensive skin rash, Stevens‑Johnson syndrome, toxic epidermal necrolysis, and, with extensive use, possible hepatic toxicity. Patients should stop treatment and seek immediate medical attention if they notice any of these severe symptoms.

Ketokonazol should be avoided in individuals with known hypersensitivity to ketoconazole or any component of the formulation. It is also contraindicated on broken skin, mucous membranes, or the eyes, and should not be used in patients who have experienced severe cutaneous adverse reactions to azole antifungals.